Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • WIPO Short Story Competition: Indigenous Ingenuity and Creativity
    • IP WRITING CHALLENGE
    Home
    >
    IP
    >
    Patents
    >
    Pharmaceutical Drugs

    Category: Pharmaceutical Drugs

    April 22, 2022in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor
    503

    Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD

    Brandon Pierre is an IPilogue Writer and a 1L JD Candidate at Osgoode Hall Law School.   In a dizzying exception to an exception of a rule, the case of…

    Read more
    April 18, 2022in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor
    447

    Ceasing Patent Enforcement from Alternative Perspectives: Russia and Moderna

    Andrew Masson is an IPilogue Writer and 1L at Osgoode Hall Law School.   Two major pieces of patent protection news with global long-lasting significance dropped in early March for…

    Read more
    February 1, 2022in Blogs, IP, Pharmaceutical Drugs0by Editor
    580

    The Competition Bureau And Health Canada Issue Joint Notice On Continued Collaboration In Pharmaceutical Sector

    M. Imtiaz Karamat is an IP Osgoode Alumnus and Associate Lawyer at Deeth Williams Wall LLP. This article was originally posted on E-TIPS™ For Deeth Williams Wall LLP on January 26,…

    Read more
    January 24, 2022in Blogs, IP, IP Intensive, Patent Practice, Patents, Pharmaceutical Drugs0by Editor
    706

    It’s a Small World in Big Pharma - My Internship at TEVA Canada Ltd.

    Vivian Sim is an IP Intensive student and a 3L JD candidate at Osgoode Hall Law School. As part of the course requirements, students were asked to write a reflective…

    Read more
    December 3, 2021in Blogs, IP, IP Intensive, Patents, Pharmaceutical Drugs0by Editor
    983

    What is a Method of Medical Treatment?

    David Park is a 3L J.D. Candidate at Osgoode Hall Law School, enrolled in Professor David Vaver’s 2021-2022 Intellectual Property Law & Technology Intensive Program. As part of the course…

    Read more
    August 25, 2021in Access to Medicines, Blogs, Patents, Pharmaceutical Drugs, US0by Editor
    1323

    Insulin Biohackers: Shaking Up a Billion-Dollar Industry

    Natalie Bravo is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School.   Brief History of Insulin In 1921, Dr. Frederick Banting, Charles Best, and James…

    Read more

    Posts navigation

    1 2 … 19
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736